As you have heard around these tables, the majority of Canadians are in favour of a national pharmacare or prescription medication program.
We have also been active in other committees that have been studying a national pharmacare program. In our observations and analysis of the TPP and in looking at the analyses of others, what we have been able to conclude is that the impact of the TPP on escalating drug prices, and also the regulatory chill that could be imposed by the TPP which might prevent negotiation within Canada of things such as a single national formulary for drugs, are factors that might prevent Canada's ability to proceed with a national pharmacare program.